Sign in

basgrootkoerkamp.bsky.social

@basgrootkoerkamp.bsky.social
104 followers 25 following 0 posts
PostsRepliesMedia
Reposted by @basgrootkoerkamp.bsky.social
Marc Besselink @marcbesselink.bsky.social · 17/02/2025
Can #Video Grading of Bile Duct Anastomoses During Robotic 🤖 #Pancreatoduodenectomy Predicts Bile Leak (BL)? ✅ Videos from 259 pts robotic HJ: 6.9% B/C BL ✅ OSATS score <21 assoc with BL ✅ The rate of BL was 5.1% for OSATS>21 vs 12.5% for OSATS ≤21 ▶️ journals.lww.com/annalsofsurg...
053
Reposted by @basgrootkoerkamp.bsky.social
Syed A Ahmad, MD @syedaahmad5.bsky.social · 19/02/2025
Failure to Rescue After Resection of Perhilar Cholangiocarcinoma in an International Multicenter Cohort ⁦‪@AnnSurgOncol‬⁩ link.springer.com/article/10.1...
link.springer.com
Failure to Rescue After Resection of Perhilar Cholangiocarcinoma in an International Multicenter Cohort - Annals of Surgical Oncology
Background Failure to rescue (FTR) is defined as the inability to prevent death after the development of a complication. FTR is a parameter in evaluating multidisciplinary postoperative complication m...
002
Reposted by @basgrootkoerkamp.bsky.social
Giovanni Marchegiani, MD PhD @gio-marchegiani.bsky.social · 20/02/2025
🧪 CA19.9 response after induction FOLFIRINOX for LAPC @bjsurgery.bsky.social 1k LAPC chemo ➡️ restaging 23% M1 😢 24% underwent surgery 🪡 📉 Baseline CA19.9 Not predictor of survival 📈 CA19.9 after induction / decrease 80% best survival academic.oup.com/bjs/article/... @bjsacademy.bsky.social
012
Reposted by @basgrootkoerkamp.bsky.social
Syed A Ahmad, MD @syedaahmad5.bsky.social · 20/02/2025
Hepatocellular carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up ⁦‪⁦‪@Annals_Oncology‬⁩ www.sciencedirect.com/science/arti...
sciencedirect.com
Hepatocellular carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
011
Reposted by @basgrootkoerkamp.bsky.social
Giovanni Marchegiani, MD PhD @gio-marchegiani.bsky.social · 22/02/2025
🧬 RNA neoantigen vaccines prime long-lived CD8+ T cells in pancreatic cancer 🎯 A milestone one in @nature.com 🦠 Responders with vaccine induced t-cells have prolonged RFS compared to non responders 💉 Vaccine for PDAC not a dream anymore www.nature.com/articles/s41... #PancreaSky #HPBSky
0103
Reposted by @basgrootkoerkamp.bsky.social
BJS Academy @bjsacademy.bsky.social · 23/02/2025
📝 Want to know how to write a clinical paper? We have a 4️⃣ part series dedicated to just that! 📽️ Watch part 2️⃣, taught by @villesallinen.bsky.social, Editor-in-Chief, of @bjsopen.bsky.social here ➡️ buff.ly/4b3QNzN #SurgSky #MedSky
buff.ly
How to write a clinical paper – Part 2 of 4
Short BJS Course – Part 2 of 4 Ville Sallinen, Editor-in-Chief, BJS Open
033
Reposted by @basgrootkoerkamp.bsky.social
Syed A Ahmad, MD @syedaahmad5.bsky.social · 23/02/2025
The Duration of Immunotherapy for Mismatch Repair–Deficient Cancers ⁦‪@NEJM‬⁩ www.nejm.org/doi/full/10....
nejm.org
The Duration of Immunotherapy for Mismatch Repair–Deficient Cancers | NEJM
An analysis of published studies suggests that a longer duration of immune checkpoint inhibitor therapy is associated with a higher incidence of complete response among patients with mismatch ...
001
Reposted by @basgrootkoerkamp.bsky.social
Prof. Feynman @proffeynman.bsky.social · 04/01/2025
The pleasure of finding things out is one of the greatest rewards of the human spirit.
0344
Reposted by @basgrootkoerkamp.bsky.social
Giovanni Marchegiani, MD PhD @gio-marchegiani.bsky.social · 05/01/2025
Perioperative Corticosteroids 💊 to reduce complications in pancreas surgery? 🧐 Meta analysis 5 studies / 1.4k pts @annsurgoncology.bsky.social Corticosteroids🫸🫷no dicrease morbidity / fistula / mortality 💡 What about mitigation strategis in high risk!? #HPBSky link.springer.com/article/10.1...
061
Reposted by @basgrootkoerkamp.bsky.social
Prof. Feynman @proffeynman.bsky.social · 03/01/2025
There is no learning without having to pose a question. And a question requires doubt.
0284
Reposted by @basgrootkoerkamp.bsky.social
Maarten van Smeden @maartenvsmeden.bsky.social · 23/12/2024
Let us start 2025 in a positive mood: here are 10 methods things researchers can worry *less* about in 2025
media.tenor.com
a countdown clock with the number 10 in the center
ALT: a countdown clock with the number 10 in the center
15259119
Reposted by @basgrootkoerkamp.bsky.social
Marc Besselink @marcbesselink.bsky.social · 23/12/2024
Nationwide 🇳🇱 outcome #robot 🤖 vs #laparoscopic #liver #surgery ? 🔑 Robot ⬇️conversion 🔑 Robot ⬇️ hospital stay 🔑 Robot ⬇️ blood loss 🔑 Robot benefits mostly based on less conversions ▶️ journals.lww.com/aosopen/full... @eahpba.bsky.social @ihpba.bsky.social
181
Reposted by @basgrootkoerkamp.bsky.social
Syed A Ahmad, MD @syedaahmad5.bsky.social · 24/12/2024
Mechanisms of metastatic colorectal cancer ⁦‪⁦‪@NatRevGastroHep‬⁩ www.nature.com/articles/s41...
nature.com
Mechanisms of metastatic colorectal cancer - Nature Reviews Gastroenterology & Hepatology
Metastatic colorectal cancer (mCRC) has a poor prognosis, and therapeutic options are limited. This Review provides a comprehensive overview of the genetic and molecular underpinnings of mCRC, discuss...
022
Reposted by @basgrootkoerkamp.bsky.social
Syed A Ahmad, MD @syedaahmad5.bsky.social · 24/12/2024
PDAC: advances in tumour microenvironment, microbiome and AI ⁦‪@NatRevGastroHep‬⁩ www.nature.com/articles/s41...
nature.com
PDAC: advances in tumour microenvironment, microbiome and AI - Nature Reviews Gastroenterology & Hepatology
Pancreatic cancer remains one of the most challenging malignancies, with a very poor prognosis. Current research is focused on elucidating the role of the tumour microenvironment and the microbiome in...
022
Reposted by @basgrootkoerkamp.bsky.social
Ville Sallinen @villesallinen.bsky.social · 25/12/2024
Our MOBILE2 trial Top4 viewed paper @jama.com/surgery with >30k views! And total two papers from Finland🇫🇮 on Top10 list. Many more trials already running, quite a few in the pipeline to be started, several new ideas under marinade! read.alerts.jamanetwork.com/csb/Public/s...
read.alerts.jamanetwork.com
Most Viewed Articles 2024
161
Reposted by @basgrootkoerkamp.bsky.social
Prof. Feynman @proffeynman.bsky.social · 20/12/2024
Play with ideas the way children play with toys—without fear of breaking them.
0457
Reposted by @basgrootkoerkamp.bsky.social
Giovanni Marchegiani, MD PhD @gio-marchegiani.bsky.social · 21/12/2024
2️⃣0️⃣2️⃣4️⃣ Pancreas Wrapped 🎄 6️⃣ June 🍇 How to prevent IPMN progression to cancer?! 🫸 🚬 Quit smoking is THE answer! Smoke correlates with HGD and invasive cancer 🚨 www.dldjournalonline.com/article/S159... #HPBSky #PancreasSky #SurgSky
082
Reposted by @basgrootkoerkamp.bsky.social
Syed A Ahmad, MD @syedaahmad5.bsky.social · 08/12/2024
Long term outcomes in EDPAC 4. The median OS was 29.5 months (27.5-32.1) for all patients, 28.4 months (25.2-32.0) in the gemcitabine group and 31.6 months (26.5-38.0) in the GemCap group ascopubs.org/doi/10.1200/...
ascopubs.org
Pancreatic Adenocarcinoma: Long-Term Outcomes of Adjuvant Therapy in the ESPAC4 Phase III Trial
PURPOSEThe ESPAC4 trial showed that adjuvant chemotherapy with gemcitabine plus capecitabine (GemCap) produced longer overall survival (OS) than gemcitabine monotherapy. Subsequently, the PRODIGE24-CC...
052
Reposted by @basgrootkoerkamp.bsky.social
Memorial Sloan Kettering Cancer Center @mskcancercenter.bsky.social · 27/11/2024
A new study in @cellpress.bsky.social Immunity from the lab of Dr. Benjamin Greenbaum provides insights into how #PancreaticCancer cells accommodate active retrotransposons without triggering the innate immune response. #oncsky #medsky
cell.com
Cancer cells restrict immunogenicity of retrotransposon expression via distinct mechanisms
Overexpression of transposable elements is a common feature of cancer. Sun, You, et al. show that, in pancreatic ductal adenocarcinoma, tumor cells adapt through different mechanisms to mitigate a spe...
02210
Reposted by @basgrootkoerkamp.bsky.social
Syed A Ahmad, MD @syedaahmad5.bsky.social · 28/11/2024
Adjuvant chemotherapy for adenocarcinoma arising from intraductal papillary mucinous neoplasia: multicentre ADENO-IPMN study academic.oup.com/bjs/article/...
academic.oup.com
Validate User
153
Reposted by @basgrootkoerkamp.bsky.social
Marc Besselink @marcbesselink.bsky.social · 20/11/2024
Today #JAMAsurg: long term outcomes #ESCAPE RCT: early #surgery remains superior to #endoscopy first in pts with wide-duct #chronic #pancreatitis ✅ Lower Izbicki pain scores ✅ Lower number of reinterventions ✅ Lower VAS pain scores ✅ Higher patient satisfaction ▶️ jamanetwork.com/journals/jam...
1185